Bumper Offer - Urjas oil Just @ Rs. 1 X
Unitrax TZ 1.125 Injection is a prescription drug, available for use as Injection. Urinary Tract Infection, Gonorrhea, Meningitis are some of its major therapeutic uses. Other than this, Unitrax TZ 1.125 Injection has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Unitrax TZ 1.125 Injection depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Unitrax TZ 1.125 Injection as well, which are listed below. These side effects of Unitrax TZ 1.125 Injection are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Unitrax TZ 1.125 Injection's effect during pregnancy is Safe and Mild while nursing. Further, the section on Unitrax TZ 1.125 Injection related warnings talks about Unitrax TZ 1.125 Injection's effects on the liver, heart and kidney.
Unitrax TZ 1.125 Injection is contraindicated in people with pre-existing medical conditions like Jaundice, Drug Allergy as it can result in adverse effects. The section on Unitrax TZ 1.125 Injection contraindications lists all such conditions.
Besides this, Unitrax TZ 1.125 Injection may also have severe interaction with some medicines. See below for a complete list.
You should also be aware that Unitrax TZ 1.125 Injection is not safe while driving, and is not addiction.
Unitrax TZ 1.125 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| Infant (1 month to 2 years) |
|
| Neonates (0 to 1 month) |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Unitrax TZ 1.125 Injection is used -
Severe
Mild
Is the use of Unitrax TZ 1.125 Injection safe for pregnant women?
Pregnant women can take Unitrax without worrying about any side effects.
Is the use of Unitrax TZ 1.125 Injection safe during breastfeeding?
Breastfeeding women can take Unitrax as it bears very minor side effects for them.
What is the effect of Unitrax TZ 1.125 Injection on the Kidneys?
Unitrax rarely affects the kidneys.
What is the effect of Unitrax TZ 1.125 Injection on the Liver?
Unitrax has very mild side effects on the liver.
What is the effect of Unitrax TZ 1.125 Injection on the Heart?
There are no any side effects of Unitrax for the heart.
Unitrax TZ 1.125 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Unitrax TZ 1.125 Injection unless your doctor advises you to do so -
Is this Unitrax TZ 1.125 Injection habit forming or addictive?
Unitrax TZ 1.125 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Unitrax TZ 1.125 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Unitrax TZ 1.125 Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Unitrax TZ 1.125 Injection is not used to treat mental disorders.
Interaction between Food and Unitrax TZ 1.125 Injection
Taking Unitrax TZ 1.125 Injection with food does not cause any problems.
Interaction between Alcohol and Unitrax TZ 1.125 Injection
Information about the interaction of Unitrax TZ 1.125 Injection and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311